Asymmetric chemoenzymatic synthesis of 1,3-diols and 2,4-disubstituted aryloxetanes by using whole cell biocatalysts

Org Biomol Chem. 2016 Dec 28;14(48):11438-11445. doi: 10.1039/c6ob02320g. Epub 2016 Nov 23.

Abstract

Regio- and stereo-selective reduction of substituted 1,3-aryldiketones, investigated in the presence of different whole cell microorganisms, was found to afford β-hydroxyketones or 1,3-diols in very good yields (up to 95%) and enantiomeric excesses (up to 96%). The enantiomerically enriched aldols, obtained with the opposite stereo-preference by baker's yeast and Lactobacillus reuteri DSM 20016 bioreduction, could then be diastereoselectively transformed into optically active syn- or anti-1,3-diols by a careful choice of the chemical reducing agent (diastereomeric ratio up to 98 : 2). The latter, in turn, were stereospecifically cyclized into the corresponding oxetanes in 43-98% yields and in up to 94% ee, thereby giving a diverse selection of stereo-defined 2,4-disubstituted aryloxetanes.

MeSH terms

  • Enzymes
  • Ethers, Cyclic / chemistry
  • Ethers, Cyclic / metabolism*
  • Kluyveromyces / cytology
  • Kluyveromyces / metabolism*
  • Limosilactobacillus reuteri / metabolism
  • Saccharomyces cerevisiae / metabolism
  • Stereoisomerism

Substances

  • Enzymes
  • Ethers, Cyclic
  • oxetane